Regulus Therapeutics Inc. (NASDAQ:RGLS) Q2 2021 Earnings Conference Call August 10, 2021 5:00 PM ET Company Participants Cris Calsada – Chief Financial Officer Jay Hagan – President and Chief Executive Officer Denis Drygin – Chief Scientific Officer Conference Call Participants Yanan Zhu – Wells Fargo Securities. Andreas Argyrides – Wedbush Securities Yi Chen – H.C. Wainwright Operator Ladies and gentlemen, thank you for standing by and welcome to the Regulus Therapeutics Second Quarter 2021 Financial Resul ...